Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Webcast

Ingevity announces change of location for 2020 Annual Meeting of Stockholders


Due to the public health impact of the coronavirus (COVID-19) outbreak, Ingevity Corporation (NYSE: NGVT) today announced a change in location for the company's 2020 Annual Meeting of Stockholders via the filing of additional proxy materials with the SEC.

As previously announced in its proxy materials, the company will hold its 2020 Annual Meeting of Stockholders at 9:30 a.m. (Eastern Time) on April 23, 2020, but it will now be held in a virtual format only, via live webcast. Stockholders of record as of the close of business on Feb. 24, 2020, can attend the virtual meeting via the internet at www.virtualshareholdermeeting.com/NGVT2020 by using the 16-digit control number included on the proxy card, voting instruction form or notice previously received.

Ingevity urges stockholders to vote and submit proxies in advance of the meeting by one of the methods described in the proxy materials used for the Annual Meeting of Stockholders.

Ingevity: Purify, Protect and Enhance
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, and brings to market products and processes that help customers solve complex problems. These products are used in a variety of demanding applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks, coatings, elastomers, bioplastics and automotive components that reduce gasoline vapor emissions. Headquartered in North Charleston, South Carolina, Ingevity operates from 25 locations around the world and employs approximately 1,850 people. The company is traded on the New York Stock Exchange (NYSE: NGVT). For more information visit www.ingevity.com.


These press releases may also interest you

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...



News published on and distributed by: